Carcinogenesis by 17b-estradiol (E2) is believed to be associated with its genotoxicity and stimulating activity of cell proliferation.
cholate. The amounts of protein were determined by using the Bradford protein assay kit (BioRad, Hercules, CA, U.S.A.). Solubilized proteins (50 mg) were electrophoresed on 2-15% SDS-polyacrylamide gels (Daiichi Pure Chemicals, Tokyo) at 200 V for 1 h, and were electrophoretically transferred to a polyvinylidene fluoride membrane (Millipore, Billerica, MA, U.S.A.) for 90 min at 6 V. Goat polyclonal antibodies against human BLM (C-18) was applied (Santa Cruz, CA, U.S.A.), and then by rabbit anti-goat immunoglobulin conjugated with horseradish peroxidase (DAKO, Glostrup, Denmark). The membrane was developed by using increased chemiluminescence using ECL Plus Western Blotting Detection Reagents (Amersham Life Science, Buckinghamshire, U.K.). Anti a-actin (ICN, Costa Mesa, CA, U.S.A.) was used to normalize the sample loading.
Cap Site Cloning The transcription start sites of BLM mRNA were determined by using an oligonucleotide-capping method 18) according to the manufacturer's instructions. The cap site of the BLM gene was amplified by PCR using 5Ј-replaced testis cDNA library supplied in Cap Site cDNA kit (NIPPONGENE, Tokyo). Briefly, primary PCR products were generated by the 5Ј anchor primer supplied in the kit and human BLM specific 3Ј primer, 5Ј-TCTCTGTGTTTC-CTGTCCTGCTGG-3Ј, and then underwent nested PCR using the 5Ј anchor primer supplied in the kit and human BLM specific 3Ј nested primer 5Ј-TGTTGGGTAGAGGTTC-ACTGAAGG-3Ј. The second PCR products were cloned into pCR2.1 (Invitrogen, Carlsbad, CA, U.S.A.).
Plasmid Construction The upstream 2341 bp fragment of BLM containing putative promoter region of BLM was amplified by using PCR and was inserted into the Bgl II site of pGL3-Basic vector (Promega, Madison, WI, U.S.A.) upstream of the firefly luciferase gene, which was used as a reporter gene (pGL3-BLM). A series of 5Ј deletion mutants were generated from pGL3-BLM by digesting with Sac I and Xho I, and then treated with exonucelase III and mung bean nuclease. BLM promoter regions with various lengths were amplified by using PCR with specific primers and were inserted again into pGL-3 Basic plasmid. pGL3-rand was made by replacing the BLM upstream region (Ϫ258 to ϩ18) with a random DNA sequence (103 bp) obtained from multi cloning sites of pBluescripts II KSϩ (Sac I to Kpn I) (Stratagene, La Jolla, CA, U.S.A.). The directions and sizes of the modified gene inserts were confirmed by sequencing.
Transient Transfection Assay The BLM promoter activity was assessed by firefly luciferase activity using Lumat LB9507 (Berthold, Bad Wildbad, Germany). Cells were subconfluently grown in phenol red-free DMEM supplemented with 10% charcoal-dextran-stripped FBS and were transfected with BLM promoter-Luc plasmid DNA mixed with FuGENE (Roche Diagnostics, Indianapolis, IN, U.S.A.) (lipofectin method). After 4 h incubation, the medium was changed and the cells were stimulated with E2 or BPA for 48 h. Other cells were treated with ICI182780 for 1 h, and then by E2 or BPA treatments. Luciferase activity and protein concentrations in lysates were measured according to the manufacturer's instructions (Promega). Each treatment was done in quadruplicates and the data were shown as a mean with standard deviations.
Statistical Analysis Statistical analysis was done by using Dunnett's test.
RESULTS
Stimulation of BLM Expression by E2 in MCF-7 Cells E2-responsive MCF-7 cells were grown in a medium containing 10 Ϫ12 -10 Ϫ10 M E2 for 48 h. Figure 1A shows that BLM mRNA levels increase markedly in a dose dependent manner. A time-course analysis indicated that BLM mRNA levels increased significantly even at 6 h after treatment with 10 Ϫ10 M E2 (Fig. 1B) . Because physiological concentrations of E2 in the blood are between pg/ml and ng/ml (10
Ϫ10
, 10 Ϫ8 M), 19 ) the effectve concentrations of Fig. 1A (10 Ϫ11 or 10 Ϫ10 M) are within or even less the physiological concentration. BLM mRNA was quantified for cells pre-treated with ER antagonist ICI182780 and then by E2. Pre-treatment with ICI182780 eliminated the increase in BLM mRNA expression by E2 to the control level (Fig. 1C) suggesting participation of ER in the stimulation of BLM mRNA. Basal levels of BLM mRNA expression slightly decreased in the presence of ICI182780, but ICI182780 itself did not affect the cell number (data not shown). To study further the participation of ER in the up-regulation of BLM expression, ER negative MDA-MB-231 cells were treated with 10 Ϫ12 -10 Ϫ9 M E2. BLM mRNA expression did not significantly increase in estrogen receptor-negative MDA-MB-231 cells at 48 h (Fig. 1D) . These results support the idea that E2 up-regulates BLM expression by ER.
BPA has a weak estrogenic activity and binds to ER. 11, 20) If ER participates in the regulation of BLM expression, BPA is also expected to affect BLM expression. Figure 2A shows that 10
Ϫ9

-10
Ϫ5 M BPA stimulates the expression of BLM dose dependently. A time-course analysis showed that 10 Ϫ5 M BPA significantly stimulated BLM mRNA expression at 24 h after treatment (Fig. 2B) . BPA also stimulates BLM expression, but needs a higher concentration to attain a similar level achieved by the effect of E2. Studies of ER affinity of BPA showed that its ER binding ability is about 1/1000 of E2 ability. [20] [21] [22] Thus, the difference in the effect on BLM expression between E2 and BPA corresponds to the difference in their affinity with ER. BPA failed to increase BLM mRNA expression in ER-negative MDA-MB-231 cells (data not shown). Figure 2C shows that ICI182780 inhibits the BPA effect on BLM expression in MCF-7 cells similatr to the ICI182780 inhibition of the E2 effect on BLM expression. ICI182780 and BPA did not affect the cell number (data not shown). These results also support the idea that ER participates in the induction of BLM expression by BPA.
Response of Cell Cycle-Associated Genes E2 and BPA stimulate cell proliferation in MCF-7 cells 11) and E2 up-regulates the expression of cell cycle-associated genes in MCF-7 cells. 14, 15) Stimulation of the expression of most cell cycle-associated genes by E2 was obvious at 24 h or later after E2 treatment in this study. Figure 3 indicates that the expression of cell cycle-associated genes cdc6, MCM5, MCM2, Myt1, PCNA and AuroraA is up-regulated at 24 h after treatment with E2 or BPA. These results are consistent with those of Frasor et al. 14) Generally, when E2 directly regulates genes, the expression of target genes is modulated within a couple of hours. 14, 15) From this fact, together with our results for the time profile of gene expression, we assume that up-regulation of cell cycle-associated genes and BLM genes may be a secondary response, not a primary response, by E2 stimulation. show by Western blotting the expression of BLM protein in MCF-7 cells by 72 h-treatment with 10 Ϫ12 -10 Ϫ9 M E2 or 10 Ϫ9 -10 Ϫ5 M BPA. E2 or BPA stimulated the expression of BLM protein at higher doses. A similar result was also observed by a 48 h-treatment (data not shown). The BLM protein was not apparently up-regulated in the ER-negative MDA-MB-231 cells (Fig. 4A ). The basal BLM protein level of MDA-MB-231 cells was higher than for MCF-7 cells.
Determination of Transcription Start Sites
To study the regulation of BLM expression by E2 treatment by identifying cis-regulatory elements in the BLM promoter region, we determined the transcription start sites of BLM by using a Cap site cloning method. The 5Ј-BLM cap site of cDNA amplified by second PCR was cloned into pCR2.1. The DNA sequence that included the capping site of BLM mRNA was determined to identify the transcription start sites of the BLM gene. From DNA sequencing of 20 independent clones, BLM was judged to be transcribed from multiple positions (Fig.  5A, asterisks) ; the position (ϩ72) was most frequent. We assume that most upstream start sites are at position (ϩ1) (Fig.  5A) .
Deletion Analysis of the BLM Promoter To define the region responsible for the BLM promoter, serial deletion mutants were constructed as described in Materials and Methods. Three cis-acting Sp1 element binding sites clustered around the 300 bp region (Fig. 5A) . Although BLM mRNA expression increased by E2-treatment (Figs. 1A, B) , suggesting that ER participates in its regulation (Figs. 1C, D) , a consensus estrogen responsive element was not found in the upstream 2 kbp region of BLM. Figure 5B shows the comparative promoter activity of a series of 5Ј-deletion mutants of pGL3-BLM and the E2 response to these mutants as assessed by luciferase activity in MCF-7 cells. The activities of pGL3(Ϫ257-ϩ78) containing three Sp1 elements and pGL3(Ϫ192-ϩ78) containing two Sp1 elements were distinct from other mutants. The activity of pGL3(Ϫ332-ϩ78) containing three Sp1 elements was less than for pGL3(Ϫ257-ϩ78), indicating that region Ϫ332 to Ϫ257 induces a negative effect on the promoter activity. Once again, pGL3(Ϫ192-ϩ78) showed marked promoter activity and pGL3(Ϫ176-ϩ78) and pGL3(Ϫ116-ϩ78) containing two Sp1 elements had little promoter activity, suggesting the region at Ϫ192 to Ϫ177 may be indispensable for BLM transcription. Both pGL3(ϩ20-ϩ78) and pGL(ϩ69-ϩ78), which have no Sp1 element, showed minimal or slight promoter activity. Figure 5B in the right shows the ratio of activity of these 5Ј-deletion mutants of pGL3-BLM with and without E2. Apparent stimulation of the promoter activity by E2 was observed for pGL3(ϩ20-ϩ78) lacking SP1, suggesting that SP1 does not directly participate in E2 response.
When the BLM upstream region at Ϫ258 to ϩ18 was replaced with a random DNA sequence (103 bp), the BLM transcription ability decreased to the level of the pGL3-basic vector (Fig. 5C) , suggesting the BLM upstream sequence (Ϫ257 to ϩ18) is essential for BLM promoter activity.
Participation of ER in Stimulation of BLM Promoter Activity Figure 6 shows that E2 and BPA stimulates BLM promoter activity in dose dependently. BPA needed about 1000 times higher concentration to attain the same levels of E2 effect. Figure 7 shows that ICI182780 eliminated the effect of E2 as assessed by luciferase activity in MCF-7 cells. Basal levels of BLM expression slightly decreased in the presence of ICI182780, but ICI182780 did not affect the number of viable cells (data not shown). These results of E2 and BPA of the effect on promoter activity by BLM support the idea that they up-regulate the expression of BLM protein by increasing the transcription of BLM.
DISCUSSION
We showed that E2 or BPA stimulated the expression of BLM protein by ER. BLM protein relates to DNA replication and recombination or DNA repair and is expressed during late S and G2 phase.
23) The expression of BLM protein is up-regulated during a log-phase and decreases at a stationary phase for various tumor cells.
16) The expression of BLM and cell cycle-associated genes was up-regulated by E2 and BPA that responding to increased cell proliferation. The up-regulation was observed at later stages after their treatment, that is, at 24 h (Figs. 1B, 2B) , suggesting that the BLM expression may be secondary after stimulation of cell proliferation by E2. On the other hand, the DNA damaging effect by E2 and BPA was observed much ealier than growth stimulation, 10) suggesting that the DNA damaging effect is a direct effect by E2 and BPA.
The 2.3 kb BLM upstream region contains no consensus estrogen responsive element, supporting also the speculation that up-regulation of BLM is not a primary but a secondary, response by E2. We believe this study is the first on BLM transcription regulation by E2 or BPA. Our findings suggest that basal BLM expression is sustained by a Sp1 transcriptional control system similar to other housekeeping genes, and that up-regulation of BLM by E2 is not mediated by SP1.
Finally, we suggest a possible role of up-regulated BLM proteins by E2 or BPA. We previously showed that E2 and BPA cause DNA damage by ER in MCF-7 cells and that BLM protein forms foci at DNA damage sites. 10) Both E2 and BPA accelerated ER positive MCF-7 cells growth, and also they caused DNA damage. This study showed that E2 and BPA markedly up-regulates the expression of BLM suggesting its participation in genomic stability during activated cell proliferation.
